Buy Ohr Pharmaceutical Stock | OHRP Stock Price & Latest News | Public
OHRP

Ohr Pharmaceutical

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About OHRP

    NeuBase Therapeutics, Inc. engages in the development of drugs for patients with genetic neurological disorder. Its pipelines include Huntington’s Disease, NT0100 Program - PATrOL Enabled gamma-PNA for Huntington's Disease, and NT0200 Program- PATrOL Enabled gamma-PNA f...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$200,23M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.78
    1 Year Low$4.21
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app